作者：
Hong,D.S. [1]
;
Garrido-Laguna,I. [2]
;
Ekmekcioglu,S. [3]
;
Falchook,G.S. [4]
;
Naing,A. [5]
;
Wheler,J.J. ;
Fu,S. ;
Moulder,S.L. ;
Piha-Paul,S. ;
Tsimberidou,A.M. ;
Wen,Y. ;
Culotta,K.S. ;
Anderes,K. ;
Davis,D.W. ;
Liu,W. ;
George,G.C. ;
Camacho,L.H. ;
PercyIvy,S. ;
Kurzrock,R.
作者单位：
Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
[1]
Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States
[2]
Apocell Molecular Profiling and Diagnostics, Houston, TX, United States
[3]
Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), University of
[4]
Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX
[5]
发布时间
2014-09-12
换一批
换一批
